… The magnitude of treatment differences for death, nonfatal reinfarction, and stroke varies
depending on whether PCI is compared with streptokinase or a fibrin-specific lytic. For example, …

… This is an executive summary of a consensus document which proposes that the term ‘valvular
AF’ is outdated and given that any definition ultimately relates to the evaluated practical …

… For the purposes of this review, the committee placed the highest priorities on reducing
overall stroke risk, periprocedural stroke risk, and periprocedural mortality. Lesser importance …

… This executive summary highlights the evidence evaluation and treatment recommendations
of the 2010 evidence evaluation process. More detailed information is available in other …

… This Executive Summary highlights the evidence evaluation and treatment recommendations
of this 2015 evidence evaluation process. Not all relevant references are cited here, …

… for stroke in observational studies. As mentioned above, the SPARCL study employed the
recurrence of stroke … with a history of stroke, and the recurrence rate of stroke in these patients …

… The 2010 Heart Failure Society of America comprehensive practice guideline addresses the
… with CAD, peripheral vascular disease, or stroke. Patients with diabetes and another major …

OBJECTIVES: BACKGROUND: The management of PFO related to cryptogenic stroke is
controversial, despite an increase in interventional closure procedures. METHODS: A …

To prevent CVD, it is important to manage dyslipidemia in addition to other risk factors. For
this purpose, we propose comprehensive risk management for the prevention of CVD. Risk …

… This Executive Summary provides an abbreviated version of the principal recommendations.
Antiplatelet therapy appears to be generally underused, perhaps in part because of a lack …